000 01473 a2200445 4500
005 20250517201018.0
264 0 _c20190715
008 201907s 0 0 eng d
022 _a1592-8721
024 7 _a10.3324/haematol.2017.174060
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKerstjens, Mark
245 0 0 _aTrametinib inhibits
_h[electronic resource]
260 _bHaematologica
_c04 2018
300 _ae147-e150 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAnimals
650 0 4 _aCell Line, Tumor
650 0 4 _aGene Rearrangement
650 0 4 _aHeterografts
650 0 4 _aHistone-Lysine N-Methyltransferase
_xgenetics
650 0 4 _aHumans
650 0 4 _aMAP Kinase Signaling System
650 0 4 _aMice
650 0 4 _aMyeloid-Lymphoid Leukemia Protein
_xgenetics
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdiagnostic imaging
650 0 4 _aPyridones
_xpharmacology
650 0 4 _aPyrimidinones
_xpharmacology
650 0 4 _aTumor Burden
_xdrug effects
650 0 4 _aras Proteins
_xgenetics
700 1 _aPinhancos, Sandra S
700 1 _aCastro, Patricia Garrido
700 1 _aSchneider, Pauline
700 1 _aWander, Priscilla
700 1 _aPieters, Rob
700 1 _aStam, Ronald W
773 0 _tHaematologica
_gvol. 103
_gno. 4
_gp. e147-e150
856 4 0 _uhttps://doi.org/10.3324/haematol.2017.174060
_zAvailable from publisher's website
999 _c28062425
_d28062425